- Home
- NETD vs PBYI Comparison
NETD vs PBYI Comparison
Compare NETD & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NETD
- PBYI
- Stock Information
- Founded
- NETD 2023
- PBYI 2010
- Country
- NETD United States
- PBYI United States
- Employees
- NETD N/A
- PBYI N/A
- Industry
- NETD
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- NETD
- PBYI Health Care
- Exchange
- NETD Nasdaq
- PBYI Nasdaq
- Market Cap
- NETD 242.3M
- PBYI 263.4M
- IPO Year
- NETD 2023
- PBYI N/A
- Fundamental
- Price
- NETD $11.35
- PBYI $5.06
- Analyst Decision
- NETD
- PBYI Strong Buy
- Analyst Count
- NETD 0
- PBYI 1
- Target Price
- NETD N/A
- PBYI $7.00
- AVG Volume (30 Days)
- NETD 247.2K
- PBYI 418.9K
- Earning Date
- NETD 01-01-0001
- PBYI 11-06-2025
- Dividend Yield
- NETD N/A
- PBYI N/A
- EPS Growth
- NETD N/A
- PBYI 434.29
- EPS
- NETD 0.29
- PBYI 0.97
- Revenue
- NETD N/A
- PBYI $238,062,000.00
- Revenue This Year
- NETD N/A
- PBYI N/A
- Revenue Next Year
- NETD N/A
- PBYI N/A
- P/E Ratio
- NETD $38.45
- PBYI $5.08
- Revenue Growth
- NETD N/A
- PBYI 8.63
- 52 Week Low
- NETD $10.68
- PBYI $2.32
- 52 Week High
- NETD $11.47
- PBYI $6.07
- Technical
- Relative Strength Index (RSI)
- NETD 56.08
- PBYI 49.39
- Support Level
- NETD $11.32
- PBYI $4.80
- Resistance Level
- NETD $11.37
- PBYI $5.52
- Average True Range (ATR)
- NETD 0.03
- PBYI 0.25
- MACD
- NETD -0.00
- PBYI -0.06
- Stochastic Oscillator
- NETD 56.36
- PBYI 31.96
About NETD Nabors Energy Transition Corp. II
Nabors Energy Transition Corp II is a blank check company.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.